Response Rate and Impact on Lipid Profiles of Obeticholic Acid Treatment for Patients with Primary Biliary Cholangitis: A Meta-Analysis
Background. Up to 40% of patients with primary biliary cholangitis (PBC) have an inadequate response to ursodeoxycholic acid (UDCA). Obeticholic acid (OCA) is considered the addition of treatment, but the response rate based on commonly referenced biochemical response criteria and lipids’ impact was...
Saved in:
Main Authors: | Yuan Gao, Li Li, Bei Li, Yutao Zhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2021/8829510 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Time to Make the Change from ‘Primary Biliary Cirrhosis’ to ‘Primary Biliary Cholangitis’
by: Angela C Cheung, et al.
Published: (2015-01-01) -
COVID-19 in Patients with Primary Biliary Cholangitis
by: М. К. Prashnova, et al.
Published: (2022-09-01) -
Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
by: Satoru Joshita, et al.
Published: (2017-01-01) -
Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 in Primary Biliary Cholangitis: A Meta-Analysis
by: Xing-Chen Yang, et al.
Published: (2017-01-01) -
Rare renal proximal tubular dysfunctions in primary biliary cholangitis
by: Xiaoxiao Shi, et al.
Published: (2024-12-01)